As a professional nurse, you are expected to apply your expertise to patient care. On
occasion, you will also be expected to share that expertise.
With evolving technology and continuous changes to regulations designed to keep up
these changes, there is usually a need to share information and expertise to inform
colleagues, leadership, patients, and other stakeholders.
In this Assignment, you will study a recent nursing informatics-related healthcare policy,
and you will share the relevant details via a fact sheet designed to inform and educate.
Review the Resources on healthcare policy and regulatory/legislative topics related to
health and nursing informatics.
Consider the role of the nurse informaticist in relation to a healthcare organization’s
compliance with various policies and regulations, such as the Medicare Access and
CHIP Reauthorization Act (MACRA).
Research and select one health or nursing informatics policy (within the past 5 years) or
regulation for further study.
The Assignment: (1 page)
Create a 1-page fact sheet that your healthcare organization could hypothetically use to
explain the health or nursing informatics policy/regulation you selected. Your fact sheet
should address the following:
Briefly and generally explain the policy or regulation you selected.
Address the impact of the policy or regulation you selected on system implementation.
Address the impact of the policy or regulation you selected on clinical care,
patient/provider interactions, and workflow.
Highlight organizational policies and procedures that are/will be in place at your
healthcare organization to address the policy or regulation you selected. Be specific.
Policy/Regulation Fact Sheet: The 21st Century Cures Act (Cures Act)
- The 21st Century Cures Act was signed into law on December 13, 2016. It is designed to speed up the development of medical products and bring forth new innovations and advances to patients needing them quicker and more efficiently (U.S. Department of Health and Human Services, n.d.)
- The law builds on the ongoing work by the FDA to incorporate patients’ perspectives of drug, devices, and biological products development.
- Cures Act improves health organizations’ ability to modernize clinical trials and clinical outcome assessment to accelerate novel medical products’ development and reviews.
- Cures Act also offers new authority to aid FDA to enhance health organizations’ ability to recruit and maintain technical, scientific, and professional experts and creates new programs for product development (FDA, n.d)….Please click the icon below to purchase full solution at $5